Top Markets
#1 Siren Siren +38.80%
#2 RedStone RedStone +24.34%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Ocean Protocol Ocean Protocol +17.20%
#5 KUB Coin KUB Coin +14.83%
#6 Perle Perle +10.80%
#7 Nosana Nosana +10.27%
#8 Arowana Arowana +9.87%
#9 Geodnet Geodnet +9.30%
#10 Nockchain Nockchain +8.82%
Coin of the day
Siren Siren
設定
言語
日本
通貨
USD
テーマ
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
株式のランク #32247
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
株価
$4.65
最終同期: 2024-07-24
時価総額
$10.63M
変化（1日）
6.66%
変化（1年）
0.00%
国
AU
取引 Medlab Clinical Limited (MDC)

カテゴリー

Healthcare
Medlab Clinical Limited（MDC）の配当利回りの履歴
Medlab Clinical Limited（銘柄コード: MDC）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Medlab Clinical Limited（MDC）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR